Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy

INTRODUCTION: This study aimed to evaluate the combined administration of anti-vascular endothelial growth factor (anti-VEGF) drugs before and during pars plana vitrectomy (PPV) and to explore its efficacy and safety in the treatment of patients with severe proliferative diabetic retinopathy (PDR)....

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xincheng, Wang, Xianhuai, Guo, Xinyu, Wang, Mengjiao, Liu, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640465/
https://www.ncbi.nlm.nih.gov/pubmed/37713065
http://dx.doi.org/10.1007/s40123-023-00803-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640465/
https://www.ncbi.nlm.nih.gov/pubmed/37713065
http://dx.doi.org/10.1007/s40123-023-00803-z

Ejemplares similares